Changes in procalcitonin in septic shock patients treated with endotoxin adsorption therapy

Ítems similars

• Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure
  per: Ikeda, T, et al.
  Publicat: (2004)
• The role of plasminogen activator inhibitor 1 measurement with endotoxin adsorption therapy (PMX-DHP) for postoperative septic shock patients
  per: Ikeda, T, et al.
  Publicat: (2007)
• Endotoxin adsorption method may affect serum procalcitonin
  per: Ikeda, T, et al.
  Publicat: (2008)
• Serum procalcitonin level correlates with endotoxin activity in patients with septic shock
  per: Adamik, B, et al.
  Publicat: (2015)
• Use of extracorporeal endotoxin elimination therapy for septic shock
  per: Adamik, BA, et al.
  Publicat: (2013)